Nanoceria, the versatile nanoparticles: Promising biomedical applications
Nanotechnology has been a boon for the biomedical field due to the freedom it provides for tailoring of pharmacokinetic properties of different drug molecules. Nanomedicine is the medical application of nanotechnology for the diagnosis, treatment and/or management of the diseases. Cerium oxide nanop...
Gespeichert in:
Veröffentlicht in: | Journal of controlled release 2021-10, Vol.338, p.164-189 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 189 |
---|---|
container_issue | |
container_start_page | 164 |
container_title | Journal of controlled release |
container_volume | 338 |
creator | Saifi, Mohd Aslam Seal, Sudipta Godugu, Chandraiah |
description | Nanotechnology has been a boon for the biomedical field due to the freedom it provides for tailoring of pharmacokinetic properties of different drug molecules. Nanomedicine is the medical application of nanotechnology for the diagnosis, treatment and/or management of the diseases. Cerium oxide nanoparticles (CNPs) are metal oxide-based nanoparticles (NPs) which possess outstanding reactive oxygen species (ROS) scavenging activities primarily due to the availability of “oxidation switch” on their surface. These NP have been found to protect from a number of disorders with a background of oxidative stress such as cancer, diabetes etc. In fact, the CNPs have been found to possess the environment-dependent ROS modulating properties. In addition, the inherent catalase, SOD, oxidase, peroxidase and phosphatase mimetic properties of CNPs provide them superiority over a number of NPs. Further, chemical reactivity of CNPs seems to be a function of their surface chemistry which can be precisely tuned by defect engineering. However, the contradictory reports make it necessary to critically evaluate the potential of CNPs, in the light of available literature. The review is aimed at probing the feasibility of CNPs to push towards the clinical studies. Further, we have also covered and censoriously discussed the suspected negative impacts of CNPs before making our way to a consensus. This review aims to be a comprehensive, authoritative, critical, and accessible review of general interest to the scientific community.
[Display omitted] |
doi_str_mv | 10.1016/j.jconrel.2021.08.033 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2564131349</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168365921004399</els_id><sourcerecordid>2564131349</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342t-91c6231a46617c7e69b9f98b06ff3be4cb378eaac61761f6cbdbbfeb3598234f3</originalsourceid><addsrcrecordid>eNqFkE9LxDAQxYMouK5-BKFHD7YmTZo2XkTEPwuLetBzSLITTck2Neku-O3Nsnv3NAPz3mPeD6FLgiuCCb_pq96EIYKvalyTCncVpvQIzUjX0pIJ0RyjWdZ1JeWNOEVnKfUY44aydoYWr2oIBqJT18X0DcUWYlKT81AM-TCqODnjId0W7zGsXXLDV6FdWMPKGeULNY4-L5MLQzpHJ1b5BBeHOUefT48fDy_l8u158XC_LA1l9VQKYnhNiWKck9a0wIUWVnQac2upBmY0bTtQyuQzJ5YbvdLagqaN6GrKLJ2jq33uGMPPBtIk818GvFcDhE2SdcMZoYQykaXNXmpiSCmClWN0axV_JcFyh0728oBO7tBJ3MmMLvvu9j7IPbYOokzGwWBy6whmkqvg_kn4A7eWe6o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2564131349</pqid></control><display><type>article</type><title>Nanoceria, the versatile nanoparticles: Promising biomedical applications</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Saifi, Mohd Aslam ; Seal, Sudipta ; Godugu, Chandraiah</creator><creatorcontrib>Saifi, Mohd Aslam ; Seal, Sudipta ; Godugu, Chandraiah</creatorcontrib><description>Nanotechnology has been a boon for the biomedical field due to the freedom it provides for tailoring of pharmacokinetic properties of different drug molecules. Nanomedicine is the medical application of nanotechnology for the diagnosis, treatment and/or management of the diseases. Cerium oxide nanoparticles (CNPs) are metal oxide-based nanoparticles (NPs) which possess outstanding reactive oxygen species (ROS) scavenging activities primarily due to the availability of “oxidation switch” on their surface. These NP have been found to protect from a number of disorders with a background of oxidative stress such as cancer, diabetes etc. In fact, the CNPs have been found to possess the environment-dependent ROS modulating properties. In addition, the inherent catalase, SOD, oxidase, peroxidase and phosphatase mimetic properties of CNPs provide them superiority over a number of NPs. Further, chemical reactivity of CNPs seems to be a function of their surface chemistry which can be precisely tuned by defect engineering. However, the contradictory reports make it necessary to critically evaluate the potential of CNPs, in the light of available literature. The review is aimed at probing the feasibility of CNPs to push towards the clinical studies. Further, we have also covered and censoriously discussed the suspected negative impacts of CNPs before making our way to a consensus. This review aims to be a comprehensive, authoritative, critical, and accessible review of general interest to the scientific community.
[Display omitted]</description><identifier>ISSN: 0168-3659</identifier><identifier>EISSN: 1873-4995</identifier><identifier>DOI: 10.1016/j.jconrel.2021.08.033</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Antioxidant ; Cerium oxide nanoparticles ; Nanoceria ; Nanozyme ; Reactive oxygen species ; Tumour microenvironment</subject><ispartof>Journal of controlled release, 2021-10, Vol.338, p.164-189</ispartof><rights>2021 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c342t-91c6231a46617c7e69b9f98b06ff3be4cb378eaac61761f6cbdbbfeb3598234f3</citedby><cites>FETCH-LOGICAL-c342t-91c6231a46617c7e69b9f98b06ff3be4cb378eaac61761f6cbdbbfeb3598234f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jconrel.2021.08.033$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Saifi, Mohd Aslam</creatorcontrib><creatorcontrib>Seal, Sudipta</creatorcontrib><creatorcontrib>Godugu, Chandraiah</creatorcontrib><title>Nanoceria, the versatile nanoparticles: Promising biomedical applications</title><title>Journal of controlled release</title><description>Nanotechnology has been a boon for the biomedical field due to the freedom it provides for tailoring of pharmacokinetic properties of different drug molecules. Nanomedicine is the medical application of nanotechnology for the diagnosis, treatment and/or management of the diseases. Cerium oxide nanoparticles (CNPs) are metal oxide-based nanoparticles (NPs) which possess outstanding reactive oxygen species (ROS) scavenging activities primarily due to the availability of “oxidation switch” on their surface. These NP have been found to protect from a number of disorders with a background of oxidative stress such as cancer, diabetes etc. In fact, the CNPs have been found to possess the environment-dependent ROS modulating properties. In addition, the inherent catalase, SOD, oxidase, peroxidase and phosphatase mimetic properties of CNPs provide them superiority over a number of NPs. Further, chemical reactivity of CNPs seems to be a function of their surface chemistry which can be precisely tuned by defect engineering. However, the contradictory reports make it necessary to critically evaluate the potential of CNPs, in the light of available literature. The review is aimed at probing the feasibility of CNPs to push towards the clinical studies. Further, we have also covered and censoriously discussed the suspected negative impacts of CNPs before making our way to a consensus. This review aims to be a comprehensive, authoritative, critical, and accessible review of general interest to the scientific community.
[Display omitted]</description><subject>Antioxidant</subject><subject>Cerium oxide nanoparticles</subject><subject>Nanoceria</subject><subject>Nanozyme</subject><subject>Reactive oxygen species</subject><subject>Tumour microenvironment</subject><issn>0168-3659</issn><issn>1873-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkE9LxDAQxYMouK5-BKFHD7YmTZo2XkTEPwuLetBzSLITTck2Neku-O3Nsnv3NAPz3mPeD6FLgiuCCb_pq96EIYKvalyTCncVpvQIzUjX0pIJ0RyjWdZ1JeWNOEVnKfUY44aydoYWr2oIBqJT18X0DcUWYlKT81AM-TCqODnjId0W7zGsXXLDV6FdWMPKGeULNY4-L5MLQzpHJ1b5BBeHOUefT48fDy_l8u158XC_LA1l9VQKYnhNiWKck9a0wIUWVnQac2upBmY0bTtQyuQzJ5YbvdLagqaN6GrKLJ2jq33uGMPPBtIk818GvFcDhE2SdcMZoYQykaXNXmpiSCmClWN0axV_JcFyh0728oBO7tBJ3MmMLvvu9j7IPbYOokzGwWBy6whmkqvg_kn4A7eWe6o</recordid><startdate>20211010</startdate><enddate>20211010</enddate><creator>Saifi, Mohd Aslam</creator><creator>Seal, Sudipta</creator><creator>Godugu, Chandraiah</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20211010</creationdate><title>Nanoceria, the versatile nanoparticles: Promising biomedical applications</title><author>Saifi, Mohd Aslam ; Seal, Sudipta ; Godugu, Chandraiah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342t-91c6231a46617c7e69b9f98b06ff3be4cb378eaac61761f6cbdbbfeb3598234f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antioxidant</topic><topic>Cerium oxide nanoparticles</topic><topic>Nanoceria</topic><topic>Nanozyme</topic><topic>Reactive oxygen species</topic><topic>Tumour microenvironment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saifi, Mohd Aslam</creatorcontrib><creatorcontrib>Seal, Sudipta</creatorcontrib><creatorcontrib>Godugu, Chandraiah</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of controlled release</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saifi, Mohd Aslam</au><au>Seal, Sudipta</au><au>Godugu, Chandraiah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nanoceria, the versatile nanoparticles: Promising biomedical applications</atitle><jtitle>Journal of controlled release</jtitle><date>2021-10-10</date><risdate>2021</risdate><volume>338</volume><spage>164</spage><epage>189</epage><pages>164-189</pages><issn>0168-3659</issn><eissn>1873-4995</eissn><abstract>Nanotechnology has been a boon for the biomedical field due to the freedom it provides for tailoring of pharmacokinetic properties of different drug molecules. Nanomedicine is the medical application of nanotechnology for the diagnosis, treatment and/or management of the diseases. Cerium oxide nanoparticles (CNPs) are metal oxide-based nanoparticles (NPs) which possess outstanding reactive oxygen species (ROS) scavenging activities primarily due to the availability of “oxidation switch” on their surface. These NP have been found to protect from a number of disorders with a background of oxidative stress such as cancer, diabetes etc. In fact, the CNPs have been found to possess the environment-dependent ROS modulating properties. In addition, the inherent catalase, SOD, oxidase, peroxidase and phosphatase mimetic properties of CNPs provide them superiority over a number of NPs. Further, chemical reactivity of CNPs seems to be a function of their surface chemistry which can be precisely tuned by defect engineering. However, the contradictory reports make it necessary to critically evaluate the potential of CNPs, in the light of available literature. The review is aimed at probing the feasibility of CNPs to push towards the clinical studies. Further, we have also covered and censoriously discussed the suspected negative impacts of CNPs before making our way to a consensus. This review aims to be a comprehensive, authoritative, critical, and accessible review of general interest to the scientific community.
[Display omitted]</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.jconrel.2021.08.033</doi><tpages>26</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0168-3659 |
ispartof | Journal of controlled release, 2021-10, Vol.338, p.164-189 |
issn | 0168-3659 1873-4995 |
language | eng |
recordid | cdi_proquest_miscellaneous_2564131349 |
source | Elsevier ScienceDirect Journals Complete |
subjects | Antioxidant Cerium oxide nanoparticles Nanoceria Nanozyme Reactive oxygen species Tumour microenvironment |
title | Nanoceria, the versatile nanoparticles: Promising biomedical applications |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T02%3A41%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nanoceria,%20the%20versatile%20nanoparticles:%20Promising%20biomedical%20applications&rft.jtitle=Journal%20of%20controlled%20release&rft.au=Saifi,%20Mohd%20Aslam&rft.date=2021-10-10&rft.volume=338&rft.spage=164&rft.epage=189&rft.pages=164-189&rft.issn=0168-3659&rft.eissn=1873-4995&rft_id=info:doi/10.1016/j.jconrel.2021.08.033&rft_dat=%3Cproquest_cross%3E2564131349%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2564131349&rft_id=info:pmid/&rft_els_id=S0168365921004399&rfr_iscdi=true |